Can elevated homocysteine impair endothelial function, and do MTHFR rs1801131 variants contribute to higher homocysteine?

Elevated homocysteine is reasonably linked to impaired endothelial function, but the clinical significance of modest elevations and the independent contribution of MTHFR rs1801131 (A1298C) are limited and context-dependent.

Clinical and vascular evidence

• Hyperhomocysteinemia is associated with reduced nitric-oxide (NO) bioavailability and impaired endothelium-dependent vasodilation. Folic-acid trials that lowered homocysteine reported improved vascular function; a newer meta-analysis found a 2.59-percentage-point increase in flow-mediated dilation.
• These findings do not prove that homocysteine lowering itself produced the improvement: folate may act directly on endothelial NO and oxidative pathways.
• Evidence that homocysteine causes clinically consequential structural vascular injury is less direct. In HOPE-2, B-vitamin therapy lowered homocysteine by approximately 28% but did not reduce major vascular events, coronary events, or stroke.

MTHFR and one-carbon metabolism

• A1298C is a mild functional MTHFR variant that can modestly reduce enzyme activity, potentially reducing 5-methyltetrahydrofolate availability for remethylating homocysteine to methionine and supporting methyl-donor production.
• However, independent effects on SAM:SAH balance, global or locus-specific DNA methylation, or homocysteine are not robustly established. A meta-analysis found no significant homocysteine difference for AC versus AA: β 0.55 µmol/L (95% CI −0.72 to 1.82).

Practical interpretation

• Folate, vitamin B12 status, renal function, and overall nutrition are more important determinants of circulating homocysteine than isolated A1298C status. B vitamins reliably lower the laboratory value, but this alone should not be assumed to prevent cardiovascular events.
• Bottom line: Homocysteine can contribute to endothelial dysfunction; vascular injury and A1298C-driven methylation or homocysteine effects remain biologically plausible but not reliably demonstrated. For a 71-year-old man, measured fasting total homocysteine and reversible nutritional or medical contributors are more informative than genotype alone.